Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Sep 26;9(9):CD010381.
doi: 10.1002/14651858.CD010381.pub3.

Extracorporeal membrane oxygenation for critically ill adults

Affiliations

Extracorporeal membrane oxygenation for critically ill adults

Aidan Burrell et al. Cochrane Database Syst Rev. .

Abstract

Background: Extracorporeal membrane oxygenation (ECMO) may provide benefit in certain populations of adults, including those with severe cardiac failure, severe respiratory failure, and cardiac arrest. However, it is also associated with serious short- and long-term complications, and there remains a lack of high-quality evidence to guide practice. Recently several large randomized controlled trials (RCTs) have been published, therefore, we undertook an update of our previous systematic review published in 2014.

Objectives: To evaluate whether venovenous (VV), venoarterial (VA), or ECMO cardiopulmonary resuscitation (ECPR) improve mortality compared to conventional cardiopulmonary support in critically ill adults.

Search methods: We used standard, extensive Cochrane search methods. The latest search date was March 2022. The search was limited to English language only.

Selection criteria: We included RCTs, quasi-RCTs, and cluster-RCTs that compared VV ECMO, VA ECMO or ECPR to conventional support in critically ill adults.

Data collection and analysis: We used standard Cochrane methods. Our primary outcome was 1. all-cause mortality at day 90 to one year. Our secondary outcomes were 2. length of hospital stay, 3. survival to discharge, 4. disability, 5. adverse outcomes/safety events, 6. health-related quality of life, 7. longer-term health status, and 8. cost-effectiveness. We used GRADE to assess certainty of evidence.

Main results: Five RCTs met our inclusion criteria, with four new studies being added to the original review (total 757 participants). Two studies were of VV ECMO (429 participants), one VA ECMO (41 participants), and two ECPR (285 participants). Four RCTs had a low risk of bias and one was unclear, and the overall certainty of the results (GRADE score) was moderate, reduced primarily due to indirectness of the study populations and interventions. ECMO was associated with a reduction in 90-day to one-year mortality compared to conventional treatment (risk ratio [RR] 0.80, 95% confidence interval [CI] 0.70 to 0.92; P = 0.002, I2 = 11%). This finding remained stable after performing a sensitivity analysis by removing the single trial with an uncertain risk of bias. Subgroup analyses did not reveal a significant subgroup effect across VV, VA, or ECPR modes (P = 0.73). Four studies reported an increased risk of major hemorrhage with ECMO (RR 3.32, 95% CI 1.90 to 5.82; P < 0.001), while two studies reported no difference in favorable neurologic outcome (RR 2.83, 95% CI 0.36 to 22.42; P = 0.32). Other secondary outcomes were not consistently reported across the studies.

Authors' conclusions: In this updated systematic review, which included four additional RCTs, we found that ECMO was associated with a reduction in day-90 to one-year all-cause mortality, as well as three times increased risk of bleeding. However, the certainty of this result was only low to moderate, limited by a low number of small trials, clinical heterogeneity, and indirectness across studies.

PubMed Disclaimer

Conflict of interest statement

AB is supported by a National Health and Medical Research Council (NHMRC) emerging leader scholarship, and is a chief investigator on the BLENDER RCT (high versus low dose oxygen in patients on VA ECMO) funded by the Medical Research Future Fund (MRFF), and the REDEEM RCT (VV ECMO in moderate to severe acute respiratory failure) funded by the MRFF.

JK: none.

PA: none.

LR: none.

ASN: none.

FM: none.

CH leads the binational ECMO registry in Australia and New Zealand, funded by the NHMRC and the Heart Foundation. She also leads the ECMO‐Rehab RCT, funded by the MRFF, and is a chief investigator on the BLENDER RCT (high versus low dose oxygen in patients on VA‐ECMO) also funded by the MRFF.

Figures

1
1
Study flow diagram.
2
2
Risk of bias summary: review authors' judgements about each risk of bias item for each included study.
3
3
Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.
1.1
1.1. Analysis
Comparison 1: All‐cause mortality: day 90 to 1 year, Outcome 1: All‐cause mortality: day 90 to 1 year
2.1
2.1. Analysis
Comparison 2: Major hemorrhage, Outcome 1: Major hemorrhage
3.1
3.1. Analysis
Comparison 3: Neurologic outcome, Outcome 1: Neurologic outcome (Cerebral Performance Category at 6 months)

Update of

References

References to studies included in this review

Belohlavek 2022 {published and unpublished data}
    1. Belohlavek J, Smalcova J, Rob D, Franek O, Smid O, Pokorna M, et al. Effect of intra-arrest transport, extracorporeal cardiopulmonary resuscitation, and immediate invasive assessment and treatment on functional neurologic outcome in refractory out-of-hospital cardiac arrest: a randomized clinical trial. JAMA 2022;8:737-47. [PMID: ] - PMC - PubMed
Combes 2018 {published data only}
    1. Combes A, Hajage D, Capellier G, Demoule A, Lavoué S, Guervilly C, et al. Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome. New England Journal of Medicine 2018;378(21):1965-75. [PMID: ] - PubMed
Lackermair 2020 {published data only}
    1. Lackermair K, Brunner S, Orban M, Peterss S, Orban M, Theiss HD, et al. Outcome of patients treated with extracorporeal life support in cardiogenic shock complicating acute myocardial infarction: 1-year result from the ECLS-Shock study. Clinical Research in Cardiology 2020;110(9):1412-20. [PMID: ] - PubMed
Peek 2009 {published data only}
    1. Peek GJ, Elbourne D, Mugford M, Tiruvoipati R, Wilson A, Allen E, et al. Randomised controlled trial and parallel economic evaluation of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR). Health Technology Assessment 2010;14(35):1-46. [PMID: ] - PubMed
    1. Peek GJ, Mugford M, Tiruvoipati R, Wilson A, Allen E, Thalanany MM, et al. Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial. Lancet 2009;374:1351-63. [PMID: ] - PubMed
Yannopoulos 2020 {published data only}
    1. Yannopoulos D, Bartos J, Raveendran G, Walser E, Connett J, Murray TA, et al. Advanced reperfusion strategies for patients with out-of-hospital cardiac arrest and refractory ventricular fibrillation (ARREST): a phase 2, single centre, open-label, randomised controlled trial. Lancet 2020;396(10265):1807-16. [PMID: ] - PMC - PubMed

References to studies excluded from this review

Angelini 2021 {unpublished data only}
    1. Angelini GD, Reeves BC, Evans J, Culliford LA, Collett L, Rogers CA. Conventional versus minimally invasive extracorporeal circulation in patients undergoing cardiac surgery: protocol for a randomised controlled trial (COMICS). Perfusion 2021;36(4):388-94. [PMID: ] - PMC - PubMed
ASERNIP‐S 2011 {published data only}
    1. Australian Safety Efficacy Register of New Interventional Procedures – Surgical. Pumpless extracorporeal lung assist device (Novalung) (Project record), 2011. database.inahta.org/article/10848 (accessed 8 August 2023). [HTA-32011000484]
Banning 2021 {unpublished data only}
    1. Banning AS, Adriaenssens T, Berry C, Bogaerts K, Erglis A, Distelmaier K. Veno-arterial extracorporeal membrane oxygenation (ECMO) in patients with cardiogenic shock: rationale and design of the randomised, multicentre, open-label EURO SHOCK trial. Eurointervention 2021;16(15):e1227-36. [PMID: ] - PMC - PubMed
Bartlett 2000 {published data only}
    1. Bartlett RH. Extracorporeal life support in the management of severe respiratory failure. Clinics in Chest Medicine 2000;21:555-61. [PMID: ] - PubMed
Bein 2011 {published data only}
    1. Bein T, Zimmermann M, Philipp A, Ramming M, Sinner B, Schmid C, et al. Addition of acetylsalicylic acid to heparin for anticoagulation management during pumpless extracorporeal lung assist. ASAIO Journal 2011;57:164-8. [PMID: ] - PubMed
Bein 2013 {published data only}
    1. Bein T, Weber-Carstens S, Goldmann A, Müller T, Staudinger T, Brederlau J, et al. Lower tidal volume strategy (approximately 3 ml/kg) combined with extracorporeal CO2 removal versus 'conventional' protective ventilation (6 ml/kg) in severe ARDS: the prospective randomized Xtravent-study. Intensive Care Medicine 2013;39(5):847-9. [PMID: ] - PMC - PubMed
Benzing 1997 {published data only}
    1. Benzing A, Mols G, Brieschal T, Geiger K. Hypoxic pulmonary vasoconstriction in nonventilated lung areas contributes to differences in hemodynamic and gas exchange responses to inhalation of nitric oxide. Anesthesiology 1997;86:1254-61. [PMID: ] - PubMed
Bonastre 2012 {published data only}
    1. Bonastre J, Suberviola B, Pozo JC, Guerrero JE, Torres A, Rodriguez A, et al. Extracorporeal lung support in patients with severe respiratory failure secondary to the 2010-2011 winter seasonal outbreak of influenza A (H1N1) in Spain [Uso de oxigenador de membrana extracorpóreo en pacientes con insuficiencia respiratoria aguda grave refractaria en la epidemia de gripe estacional 2010–2011 por influenza A (H1N1) en España]. Medicina Intensiva 2012;36:193-9. [PMID: ] - PubMed
Brunner 2019 {published data only}
    1. Brunner S, Guenther SP, Lackermair K, Peterss S, Orban M, Boulesteix AL. Extracorporeal life support in cardiogenic shock complicating acute myocardial infarction. Journal of the American College of Cardiology 2019;73(28):2355-7. [PMID: ] - PubMed
Crucean 2010 {published data only}
    1. Crucean AC, Peek GJ. CESAR study: justification of extracorporeal membrane oxygenation for severe adult respiratory failure [Étude CESAR: justification de l'assistance respiratoire extra corporelle pour les graves syndromes de détresse respiratoire de l'adulte]. IRBM 2010;31:S46-51. [DOI: 10.1016/S1959-0318(10)70009-9] - DOI
Cypel 2010 {published data only}
    1. Cypel M, Fischer S, Reynolds S, Pierre A, De Perrot M, Yeung JC, et al. Safety and efficacy of the Novalung interventional lung assist (iLA) device as a bridge to lung transplantation. Journal of Heart and Lung Transplantation 2010;29(2 Suppl):S21.
Gille 1974 {published data only}
    1. Gille JP, De Miguel E, Polu JM, Lambert H, Sadoul P. Extracorporeal circulation using a membrane artificial lung for respiratory assistance [Circulation extracorporelle avec poumon artificiel à membrane dans les assistances respiratoires]. Poumon et Le Coeur 1974;30:63-71. [PMID: ] - PubMed
Goligher 2018 {published data only}
    1. Goligher EC, Tomlinson G, Hajage D, Wijeysundera DN, Fan E, Jüni P, et al. Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome and posterior probability of mortality benefit in a post hoc bayesian analysis of a randomized clinical trial. JAMA 2018;320(21):2251-9. [PMID: ] - PubMed
Hsu 2021 {published data only}
    1. Hsu CH, Meurer WJ, Domeier R, Fowler J, Whitmore SP, Bassin BS, et al. Extracorporeal cardiopulmonary resuscitation for refractory out-of-hospital cardiac arrest (EROCA): results of a randomized feasibility trial of expedited out-of-hospital transport. Annals of Emergency Medicine 2021;78(1):92-101. [PMID: ] - PMC - PubMed
Kornelyuk 2020 {published data only}
    1. Kornelyuk RA, Shukevich DL, Vereshchagin IE, Ganyukov VI. Organoprotective effects of extracorporeal membrane oxygenation and intra-aortic balloon pump in high-risk percutaneous coronary intervention in patients with acute coronary syndrome. Obshchaya reanimatologiya 2020;16(1):16-26.
Levy 2022 {published data only}
    1. Levy B, Girerd N, Amour J, Besnier E, Nesseler N, Helms J, et al. Effect of moderate hypothermia vs normothermia on 30-day mortality in patients with cardiogenic shock receiving venoarterial extracorporeal membrane oxygenation: a randomized clinical trial. JAMA 2022;327(5):442-53. [PMID: ] - PMC - PubMed
Morris 1994 {published data only}
    1. Morris AH, Wallace CJ, Menlove RL, Clemmer TP, Orme JF Jr, Weaver LK, et al. Randomized clinical trial of pressure-controlled inverse ratio ventilation and extracorporeal CO2 removal for adult respiratory distress syndrome. American Journal of Respiratory and Critical Care Medicine 1994;2(149):295-310. [PMID: ] - PubMed
Muller‐Eising 2014 {published data only}
    1. Muller-Eising K, Honicka M, Rupp P, Deininger S, Kunert A, et al. Less inflammation by off-pump surgery? A randomized comparison to minimized extracorporeal circulation and conventional coronary bypass grafting. Thoracic and Cardiovascular Surgeon 2014;62(1):SC113.
Zapol 1979 {published data only}
    1. Zapol WM, Snider MT, Hill JD, Fallat RJ, Bartlett RH, Edmunds LH, et al. Extracorporeal membrane oxygenation in severe acute respiratory failure. A randomized prospective study. JAMA 1979;242:2193-6. [PMID: ] - PubMed

References to ongoing studies

Bol 2019 {published data only}
    1. Bol ME, Suverein MM, Lorusso R, Delnoij TS, Brandon Bravo Bruinsma GJ, Otterspoor L, et al. Early initiation of extracorporeal life support in refractory out-of-hospital cardiac arrest: design and rationale of the INCEPTION trial. American Heart Journal 2019;210:58-68. [PMID: ] - PubMed
ChiCTR1900021136 {unpublished data only}
    1. ChiCTR1900021136. Early application of ECMO in severe respiratory failure patients. www.chictr.org.cn/showproj.aspx?proj=35672 (first received 29 January 2019).
Jacquot 2019 {published data only}
    1. Jacquot A, Lepage X, Merckle L, Girerd N, Levy B. Protocol for a multicentre randomised controlled trial evaluating the effects of moderate hypothermia versus normothermia on mortality in patients with refractory cardiogenic shock rescued by venoarterial extracorporeal membrane oxygenation (VA-ECMO) (HYPO-ECMO study). BMJ Open 2019;9(10):e031697. [PMID: ] - PMC - PubMed
NCT02301819 {published data only}
    1. NCT02301819. ExtraCorporeal Membrane Oxygenation in the Therapy of Cardiogenic Shock (ECMO-CS). clinicaltrials.gov/study/NCT02301819 (first received 26 November 2014).
NCT03637205 {published data only}
    1. NCT03637205. Extracorporeal Life Support in Cardiogenic Shock (ECLS-SHOCK). clinicaltrials.gov/study/NCT03637205 (first received 13 August 2018).
NCT03813134 {published data only}
    1. NCT03813134. Testing the value of novel strategy and its cost efficacy in order to improve the poor outcomes in cardiogenic shock (EUROSHOCK). clinicaltrials.gov/study/NCT03813134 (first received 19 December 2018).
NCT04184635 {unpublished data only}
    1. NCT04184635. Assessment of ECMO in acute myocardial infarction cardiogenic shock (ANCHOR). clinicaltrials.gov/study/NCT04184635 (first received 28 November 2019).
NCT04208126 {unpublished data only}
    1. NCT04208126. Early versus late initiation of ECMO (extracorporal membrane oxygenation) trial (ELIEO-trial). clinicaltrials.gov/study/NCT04208126 (first received 5 December 2019). [NCT: 04208126]
NCT04555798 {unpublished data only}
    1. NCT04555798. Effect of arterio-venous ECMO on severe sepsis and ARDS. clinicaltrials.gov/study/NCT04555798 (first received 14 September 2020). [NCT: 04555798]
NCT04620070 {published data only}
    1. NCT04620070. ON-SCENE initiation of extracorporeal cardiopulmonary resuscitation during refractory out-of-hospital cardiac arrest (ON-SCENE). clinicaltrials.gov/study/NCT04620070 (first received 26 October 2020).
Thiele 2021 {published data only}
    1. Thiele H, Freund A, Gimenez MR, Waha-Thiele S, Akin I, Poss J, et al. Extracorporeal life support in patients with acute myocardial infarction complicated by cardiogenic shock – design and rationale of the ECLS-SHOCK trial. American Heart Journal 2021;234:1-11. [PMID: ] - PubMed

Additional references

Ahn 2016
    1. Ahn C, Kim W, Cho Y, Choi KS, Jang BH, Lim TH. Efficacy of extracorporeal cardiopulmonary resuscitation compared to conventional cardiopulmonary resuscitation for adult cardiac arrest patients: a systematic review and meta-analysis. Science Report 2016;6:34208. [PMID: ] - PMC - PubMed
ARDS Network 2000
    1. Acute Respiratory Distress Syndrome Network, Brower RG, Matthay MA, Morris A, Schoenfeld D, Thompson BT, Wheeler A. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. New England Journal of Medicine 2000;342(18):1301-8. [DOI: 10.1056/NEJM200005043421801] [PMID: ] - DOI - PubMed
Bein 2013
    1. Bein T, Weber-Carstens S, Goldmann A, Müller T, Staudinger T, Brederlau J, et al. Lower tidal volume strategy (≈3 ml/kg) combined with extracorporeal CO2 removal versus 'conventional' protective ventilation (6 ml/kg) in severe ARDS: the prospective randomized Xtravent-study. Intensive Care Medicine 2013;39(5):847-56. [PMID: ] - PMC - PubMed
Bellani 2016
    1. Bellani G, Laffey JG, Pham T, Fan E, Brochard L, Esteban A, et al. Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries. JAMA 2016;315(8):788-800. [PMID: ] - PubMed
Benjamin 2019
    1. Benjamin EJ, Muntner P, Alonso A, Bittencourt MS, Callaway CW, Carson AP, et al. Heart disease and stroke statistics – 2019 update: a report from the American Heart Association. Circulation 2019;139(10):e56-e528. [PMID: ] - PubMed
Burrell 2019
    1. Burrell AJ, Bennett V, Serra AL, Pellegrino VA, Romero L, Fan E, et al. International ECMO Network (ECMONet). Venoarterial extracorporeal membrane oxygenation: a systematic review of selection criteria, outcome measures and definitions of complications. Journal of Critical Care 2019;53:32-7. [PMID: ] - PubMed
Chalwin 2008
    1. Chalwin RP, Moran JL, Graham PL. The role of extracorporeal membrane oxygenation for treatment of the adult respiratory distress syndrome: review and quantitative analysis. Anaesthesia and Intensive Care 2008;36(2):152-61. [PMID: ] - PubMed
Combes 2019
    1. Combes A, Fanelli V, Pham T, Ranieri VM. European Society of Intensive Care Medicine Trials Group and the "Strategy of Ultra-Protective lung ventilation with Extracorporeal CO2 Removal for New-Onset moderate to severe ARDS" (SUPERNOVA) investigators. Feasibility and safety of extracorporeal CO2 removal to enhance protective ventilation in acute respiratory distress syndrome: the SUPERNOVA study. Intensive Care Medicine 2019;45(5):592-600. [PMID: ] - PubMed
Combes 2020
    1. Combes A, Peek GJ, Hajage D, Hardy P, Abrams D, Schmidt M, et al. ECMO for severe ARDS: systematic review and individual patient data meta-analysis. Intensive Care Medicine 2020;46(11):2048-57. [PMID: ] - PMC - PubMed
ELSO 2022
    1. Extracorporeal Life Support Organization (ELSO). ECLS International Summary of Statistics – April 2022. www.elso.org/portals/0/files/reports/2022_april/international%20report%2... (accessed 8 August 2023).
Fan 2016
    1. Fan E, Gattinoni L, Combes A, Schmidt M, Peek G, Brodie D, et al. Venovenous extracorporeal membrane oxygenation for acute respiratory failure: a clinical review from an international group of experts. Intensive Care Medicine 2016;42(5):712-24. [PMID: ] - PubMed
Featherstone 2018
    1. Featherstone PJ, Ball CM. The early history of extracorporeal membrane oxygenation. Anaesthesia and Intensive Care 2018;46(6):555-7. [PMID: ] - PubMed
Goto 2016
    1. Goto Y, Funada A, Goto Y. Relationship between the duration of cardiopulmonary resuscitation and favorable neurological outcomes after out-of-hospital cardiac arrest: a prospective, nationwide, population-based cohort study. Journal of American Heart Association 2016;5(3):e002819. [PMID: ] - PMC - PubMed
Gravesteijn 2020
    1. Gravesteijn BY, Schluep M, Disli M, Garkhail P, Dos Reis MD, Stolker R, et al. Neurological outcome after extracorporeal cardiopulmonary resuscitation for in-hospital cardiac arrest: a systematic review and meta-analysis. Crit Care 2020;24:505. [DOI: 10.1186/s13054-020-03201-0] - DOI - PMC - PubMed
Higgins 2011
    1. Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from training.cochrane.org/handbook/archive/v5.1/.
Higgins 2019
    1. Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions. 2nd edition. Chichester (UK): John Wiley & Sons, 2019.
Hill 1972
    1. Hill JD, O'Brien TG, Murray JJ, Dontigny L, Bramson ML, Osborn JJ, et al. Prolonged extracorporeal oxygenation for acute post-traumatic respiratory failure (shock-lung syndrome) — use of the Bramson membrane lung. New England Journal of Medicine 1972;286:629-34. [DOI: 10.1056/NEJM197203232861204] - DOI - PubMed
Hodgson 2017
    1. Hodgson CL, Udy AA, Bailey M, Barrett J, Bellomo R, Bucknall T, et al. The impact of disability in survivors of critical illness. Intensive Care Medicine 2017;43(7):992-1001. [PMID: ] - PubMed
Hodgson 2019
    1. Hodgson CL, Burrell AJ, Engeler DM, Pellegrino VA, Brodie D, Fan E. International ECMO Network. Core outcome measures for research in critically ill patients receiving extracorporeal membrane oxygenation for acute respiratory or cardiac failure: an international, multidisciplinary, modified Delphi consensus study. Critical Care Medicine 2019;47(11):1557-63. [PMID: ] - PubMed
Hodgson 2021
    1. Hodgson CL, Fulcher B, Mariajoseph FP, Burrell AJ, Pellegrino V, Brodie D, et al. SCOPE Study Investigators on behalf of the International ECMO Network. A core outcome set for research in patients on extracorporeal membrane oxygenation. Critical Care Medicine 2021;49(12):e1252-4. [PMID: ] - PubMed
Holmberg 2018
    1. Holmberg MJ, Geri G, Wiberg S, Guerguerian AM, Donnino MW, Nolan JP, et al. Extracorporeal cardiopulmonary resuscitation for cardiac arrest: a systematic review. Resuscitation 2018;131:91-100. [PMID: ] - PMC - PubMed
Lackermair 2021
    1. Lackermair K, Brunner S, Orban M, Peterss S, Orban M, Theiss HD, et al. Outcome of patients treated with extracorporeal life support in cardiogenic shock complicating acute myocardial infarction: 1-year result from the ECLS-Shock study. Clinical Research in Cardiology 2021;110(9):1412-20. [PMID: ] - PubMed
Ling 2021
    1. Ling RR, Ramanathan K, Poon WH, Tan CS, Brechot N, Brodie D, et al. Venoarterial extracorporeal membrane oxygenation as mechanical circulatory support in adult septic shock: a systematic review and meta-analysis with individual participant data meta-regression analysis. Critical Care 2021;25(1):246. [PMID: ] - PMC - PubMed
McNamee 2021
    1. McNamee JJ, Gillies MA, Barrett NA, Perkins GD, Tunnicliffe W, Young D, et al. Effect of lower tidal volume ventilation facilitated by extracorporeal carbon dioxide removal vs standard care ventilation on 90-day mortality in patients with acute hypoxemic respiratory failure: the REST randomized clinical trial. JAMA 2021;326(11):1013-23. [PMID: ] - PMC - PubMed
Munshi 2019
    1. Munshi L, Walkey A, Goligher E, Pham T, Uleryk EM, Fan E. Venovenous extracorporeal membrane oxygenation for acute respiratory distress syndrome: a systematic review and meta-analysis. Lancet 2019;7(2):163-72. [PMID: ] - PubMed
Oude Lansink‐Hartgring 2021
    1. Oude Lansink-Hartgring A, Minnen O, Vermeulen KM, den Bergh WM. Dutch extracorporeal life support study group. Hospital costs of extracorporeal membrane oxygenation in adults: a systematic review. Pharmacoeconomics Open 2021;5(4):613-23. [PMID: ] - PMC - PubMed
Peek 2006
    1. Peek GJ, Clemens F, Elbourne D, Firmin R, Hardy P, Hibbert C, et al. CESAR: conventional ventilatory support vs extracorporeal membrane oxygenation for severe adult respiratory failure. BMC Health Service Research 2006;6:163. [PMID: ] - PMC - PubMed
Ramanathan 2021
    1. Ramanathan K, Shekar K, Ling RR, Barbaro RP, Wong SN, Tan CS, et al. Extracorporeal membrane oxygenation for COVID-19: a systematic review and meta-analysis. Critical Care 2021;25:211. - PMC - PubMed
Rao 2018
    1. Rao P, Khalpey Z, Smith R, Burkhoff D, Kociol RD. Venoarterial extracorporeal Membrane oxygenation for cardiogenic shock and cardiac arrest cardinal considerations for initiation and management. Circulation: Heart Failure 2018;11(9):e004905. [PMID: ] - PubMed
RevMan Web 2022 [Computer program]
    1. Review Manager Web (RevMan Web). Version 4.12.0. The Cochrane Collaboration, 2022. Available at revman.cochrane.org.
Richardson 2017
    1. Richardson AS, Schmidt M, Bailey M, Pellegrino VA, Rycus PT, Pilcher DV. ECMO cardio-pulmonary resuscitation (ECPR), trends in survival from an international multicentre cohort study over 12-years. Resuscitation 2017;112:34-40. [PMID: ] - PubMed
Scquizzato 2022
    1. Scquizzato T, Bonaccorso A, Consonni M, Scandroglio AM, Swol J, Landoni G, et al. Extracorporeal cardiopulmonary resuscitation for out-of-hospital cardiac arrest: a systematic review and meta-analysis of randomized and propensity score-matched studies. Artificial Organs 2022;46(5):755-62. [PMID: ] - PMC - PubMed
Terragni 2014
    1. Terragni P, Faggiano C, Ranieri VM. Extracorporeal membrane oxygenation in adult patients with acute respiratory distress syndrome. Current Opinion in Critical Care 2014;20(1):86-91. [PMID: ] - PubMed
Vahdatpour 2019
    1. Vahdatpour C, Collins D, Goldberg S. Cardiogenic shock. Journal of American Heart Association 2019;17(8):e011991. [PMID: ] - PMC - PubMed
Vaquer 2017
    1. Vaquer S, Haro C, Peruga P, Oliva JC, Artigas A. Systematic review and meta-analysis of complications and mortality of veno-venous extracorporeal membrane oxygenation for refractory acute respiratory distress syndrome. Annals of Intensive Care 2017;7(1):51. - PMC - PubMed
Vos 2019
    1. Vos T, Lim S, Abbafati S, Abbas K, Abbasi M, Abbasifard M, et al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet 2020;396(10258):1204-22. [PMID: ] - PMC - PubMed
Wilson‐Smith 2019
    1. Wilson-Smith AR, Bogdanova Y, Roydhouse S, Phan K, Tian DH, Yan TD, et al. Outcomes of venoarterial extracorporeal membrane oxygenation for refractory cardiogenic shock: systematic review and meta-analysis. Annals of Cardiothoracic Surgery 2019;8(1):1-8. [PMID: ] - PMC - PubMed
Zampieri 2013
    1. Zampieri FG, Mendes PV, Ranzani OT, Taniguchi L, Pontes Azevedo LC, Vieira Costa EL, et al. Extracorporeal membrane oxygenation for severe respiratory failure in adult patients: a systematic review and meta-analysis of current evidence. Journal of Critical Care 2013;28(6):998-1005. [PMID: ] - PubMed
Zangrillo 2013
    1. Zangrillo A, Landoni G, Biondi-Zoccai G, Greco M, Greco T, Frati G, et al. A meta-analysis of complications and mortality of extracorporeal membrane oxygenation. Critical Care and Resuscitation 2013;15(3):172-8. [PMID: ] - PubMed
Zapol 1979
    1. Zapol WM, Snider MT, Hill JD, Fallat RJ, Bartlett RH, Edmunds LH, et al. Extracorporeal membrane oxygenation in severe acute respiratory failure. A randomized prospective study. JAMA 1979;242(20):2193-6. [PMID: ] - PubMed

References to other published versions of this review

Tramm 2013
    1. Tramm R, Ilic D, Davies AR, Pellegrino VA, Hodgson C. Extracorporeal membrane oxygenation for critically ill adults. Cochrane Database of Systematic Reviews 2013, Issue 2. Art. No: CD010381. [DOI: 10.1002/14651858.CD010381] - DOI - PMC - PubMed
Tramm 2015
    1. Tramm R, Ilic D, Davies AR, Pellegrino VA, Romero L, Hodgson C. Extracorporeal membrane oxygenation for critically ill adults. Cochrane Database of Systematic Reviews 2015, Issue 1. Art. No: CD010381. [DOI: 10.1002/14651858.CD010381.pub2] [PMID: ] - DOI - PMC - PubMed

Publication types

LinkOut - more resources